Ecosystem

Turning Dutch scientific strength into real solutions for cancer patients

Innovations like organoids, advanced human tissue models, and organ-on-a-chip platforms are a testament to the Netherlands being a leading player in high-end oncology research. How can we leverage those scientific advancements into better outcomes for cancer patients? That question was at the centre of a conversation between Friso Smit, COO of the Oncode Accelerator Foundation, and Bas Trietsch, CTO and cofounder of Mimetas, during a BiotechNews live on-stage interview at Innovation for Health 2026.

Ecosystem

Turning Dutch scientific strength into real solutions for cancer patients

Innovations like organoids, advanced human tissue models, and organ-on-a-chip platforms are a testament to the Netherlands being a leading player in high-end oncology research. How can we leverage those scientific advancements into better outcomes for cancer patients? That question was at the centre of a conversation between Friso Smit, COO of the Oncode Accelerator Foundation, and Bas Trietsch, CTO and cofounder of Mimetas, during a BiotechNews live on-stage interview at Innovation for Health 2026.

Ecosystem

Turning Dutch scientific strength into real solutions for cancer patients

Innovations like organoids, advanced human tissue models, and organ-on-a-chip platforms are a testament to the Netherlands being a leading player in high-end oncology research. How can we leverage those scientific advancements into better outcomes for cancer patients? That question was at the centre of a conversation between Friso Smit, COO of the Oncode Accelerator Foundation, and Bas Trietsch, CTO and cofounder of Mimetas, during a BiotechNews live on-stage interview at Innovation for Health 2026.

Top stories

MORE

Top stories

MORE

Career

What becomes possible when we stop suppressing neurodiversity?

Career

Curiosity, Courage, and Teamwork: Sanne Weijzen on Building a Meaningful Career

Career

Curiosity, Courage, and Teamwork: Sanne Weijzen on Building a Meaningful Career

Career

Curiosity, Courage, and Teamwork: Sanne Weijzen on Building a Meaningful Career

Opinion

A first rate knowledge economy needs a first rate access model

Opinion

A first rate knowledge economy needs a first rate access model

Opinion

A first rate knowledge economy needs a first rate access model

Career

From Building Blocks to Biotech Breakthroughs: Nazma Ilahibaks on Leading JAMA Therapeutics

Career

From Building Blocks to Biotech Breakthroughs: Nazma Ilahibaks on Leading JAMA Therapeutics

Career

From Building Blocks to Biotech Breakthroughs: Nazma Ilahibaks on Leading JAMA Therapeutics

Career

Leadership Without Noise - Barbara Brunnhuber on principles, thin skin, and the kind of leadership biotech actually needs

Career

Leadership Without Noise - Barbara Brunnhuber on principles, thin skin, and the kind of leadership biotech actually needs

Career

Leadership Without Noise - Barbara Brunnhuber on principles, thin skin, and the kind of leadership biotech actually needs

Advertisement

Advertisement

Career

MORE

Career

MORE

Career

argenx Appoints Karen Massey as New CEO

Career

argenx Appoints Karen Massey as New CEO

Career

argenx Appoints Karen Massey as New CEO

Career

Genmab CEO Jan van de Winkel Named CEO of the Year by Danish Biotech Association

Career

Genmab CEO Jan van de Winkel Named CEO of the Year by Danish Biotech Association

Career

Genmab CEO Jan van de Winkel Named CEO of the Year by Danish Biotech Association

Career

Breakthrough Prize for ALS-dementia gene discovery awarded to Rosa Rademakers

Career

Breakthrough Prize for ALS-dementia gene discovery awarded to Rosa Rademakers

Career

Breakthrough Prize for ALS-dementia gene discovery awarded to Rosa Rademakers

Career

Biotech Booster announces changes in its Board of Directors

Career

Biotech Booster announces changes in its Board of Directors

Career

Biotech Booster announces changes in its Board of Directors

Career

May 7, 2026

argenx Appoints Karen Massey as New CEO

Jobs at BCF Career

MORE

The European Medicines Agency (EMA)

Scientific (SME) Officer

The European Medicines Agency (EMA)

Scientific (SME) Officer

The European Medicines Agency (EMA)

Senior Medicines and Medical Devices Shortages Specialist

The European Medicines Agency (EMA)

Senior Medicines and Medical Devices Shortages Specialist

Enza Zaden

Manager Molecular Breeding

Enza Zaden

Manager Molecular Breeding

Oncode Accelerator

Business Development Manager

Oncode Accelerator

Business Development Manager

Agomab

Lead Biologist Drug Discovery

Agomab

Lead Biologist Drug Discovery

Result Laboratorium

Afdelingshoofd Laboratorium

Result Laboratorium

Afdelingshoofd Laboratorium

SBMC

Senior Lab Technician

SBMC

Senior Lab Technician

The European Medicines Agency (EMA)

Scientific (SME) Officer

The European Medicines Agency (EMA)

Senior Medicines and Medical Devices Shortages Specialist

Enza Zaden

Manager Molecular Breeding

Oncode Accelerator

Business Development Manager

Events

MORE

Events

MORE

May 21, 2026

BCF Career Event Netherlands - Jaarbeurs Utrecht

May 21, 2026

BCF Career Event Netherlands - Jaarbeurs Utrecht

Jun 22, 2026

BioBusiness Summer School

Jun 22, 2026

BioBusiness Summer School

Oct 7, 2026

Dutch Medicines Days

Oct 7, 2026

Dutch Medicines Days

Nov 26, 2026

BCF Career Event Belgium - Flanders Expo

Nov 26, 2026

BCF Career Event Belgium - Flanders Expo

May 21, 2026

BCF Career Event Netherlands - Jaarbeurs Utrecht

Jun 22, 2026

BioBusiness Summer School

Oct 7, 2026

Dutch Medicines Days

Nov 26, 2026

BCF Career Event Belgium - Flanders Expo

Mar 10, 2027

Global Investor Forum

Mar 11, 2027

Innovation for Health

Contributions

MORE

Mariska Koster

Farma lobby

Mariska Koster

Farma lobby

Mariska Koster

Farma lobby

Maak van Nederland dé Europese biotech hub!

Maak van Nederland dé Europese biotech hub!

Maak van Nederland dé Europese biotech hub!

Henk Jan Out

Repurposing, dé oplossing voor betere toegang tot geneesmiddelen?

Henk Jan Out

Repurposing, dé oplossing voor betere toegang tot geneesmiddelen?

Henk Jan Out

Repurposing, dé oplossing voor betere toegang tot geneesmiddelen?

Eline van Beest

“Zie je wel… het kan wel in Europa.”

Eline van Beest

“Zie je wel… het kan wel in Europa.”

Eline van Beest

“Zie je wel… het kan wel in Europa.”

Innovation

MORE

Innovation

May 11, 2026

HAN BioCentre partner in Groeifonds Cellulaire Agricultuur en FungCows

Innovation

Utrecht scientists reveal that metastasis-related changes occur early in colon cancer

Innovation

Utrecht scientists reveal that metastasis-related changes occur early in colon cancer

Innovation

An important step forward in the fight against antimicrobial resistance (AMR)

Innovation

An important step forward in the fight against antimicrobial resistance (AMR)

Innovation

Syntric Medical Wins Venture Challenge Medtech Winter 2026 Edition

Innovation

Syntric Medical Wins Venture Challenge Medtech Winter 2026 Edition

Innovation

From overlooked to in demand: Femtech in focus at Women’s Health Pitch Session at I4H2026

Innovation

From overlooked to in demand: Femtech in focus at Women’s Health Pitch Session at I4H2026

Innovation

UMC Utrecht Researcher Tim Sakkers Wins the I4H Young Innovator Award 2026 with ReveltaDx: Transforming Heart Disease Diagnosis in Women

Innovation

UMC Utrecht Researcher Tim Sakkers Wins the I4H Young Innovator Award 2026 with ReveltaDx: Transforming Heart Disease Diagnosis in Women

Innovation

Utrecht scientists reveal that metastasis-related changes occur early in colon cancer

Innovation

An important step forward in the fight against antimicrobial resistance (AMR)

Innovation

Syntric Medical Wins Venture Challenge Medtech Winter 2026 Edition

Advertisement

Advertisement

Industry

MORE

Industry

MORE

Industry

End of an Era: Galapagos Changes Name to Lakefront Biotherapeutics

Industry

End of an Era: Galapagos Changes Name to Lakefront Biotherapeutics

Industry

End of an Era: Galapagos Changes Name to Lakefront Biotherapeutics

Industry

Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline

Industry

Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline

Industry

Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline

Partnerships

MORE

Partnerships

MORE

Partnerships

UCB to acquire Candid Therapeutics, building upon its existing immunology pipeline with novel T-cell engagers

Partnerships

UCB to acquire Candid Therapeutics, building upon its existing immunology pipeline with novel T-cell engagers

Partnerships

UCB to acquire Candid Therapeutics, building upon its existing immunology pipeline with novel T-cell engagers

Partnerships

Afrigen Biologics Announces RSV mRNA Vaccine Collaboration with RespIP BV

Partnerships

Afrigen Biologics Announces RSV mRNA Vaccine Collaboration with RespIP BV

Partnerships

Afrigen Biologics Announces RSV mRNA Vaccine Collaboration with RespIP BV

Ecosystem

MORE

Ecosystem

MORE

Ecosystem

One Billion Euro in Impact: Venture Challenge Reaches a Major Milestone for Dutch Life Sciences

Ecosystem

One Billion Euro in Impact: Venture Challenge Reaches a Major Milestone for Dutch Life Sciences

Ecosystem

One Billion Euro in Impact: Venture Challenge Reaches a Major Milestone for Dutch Life Sciences

Ecosystem

Utrecht Region: A Maturing Biotech Hub Steps Forward

Ecosystem

Utrecht Region: A Maturing Biotech Hub Steps Forward

Ecosystem

Utrecht Region: A Maturing Biotech Hub Steps Forward

Opinion

MORE

Opinion

MORE

Opinion

Farma lobby

Opinion

Farma lobby

Opinion

Farma lobby

Opinion

A first rate knowledge economy needs a first rate access model

Opinion

A first rate knowledge economy needs a first rate access model

Opinion

A first rate knowledge economy needs a first rate access model

Startups

MORE

Startups

MORE

Startup

Social Medicines drives systemic change—turning public research into sustained public access at scale

Startup

Social Medicines drives systemic change—turning public research into sustained public access at scale

Startup

Daranamix wins Proefdiervrij Venture Challenge 2026

Startup

Daranamix wins Proefdiervrij Venture Challenge 2026

Startup

Myriagon is addressing unmet needs in chemotherapy-induced peripheral neuropathy treatment

Startup

Myriagon is addressing unmet needs in chemotherapy-induced peripheral neuropathy treatment

Startup

TIBEAY Biosciences raises EUR 35 million for a Phase 3b trial of Ronopterin in traumatic brain injury

Startup

TIBEAY Biosciences raises EUR 35 million for a Phase 3b trial of Ronopterin in traumatic brain injury

Startup

Social Medicines drives systemic change—turning public research into sustained public access at scale

Startup

Daranamix wins Proefdiervrij Venture Challenge 2026

Startup

Myriagon is addressing unmet needs in chemotherapy-induced peripheral neuropathy treatment

Startup

TIBEAY Biosciences raises EUR 35 million for a Phase 3b trial of Ronopterin in traumatic brain injury

Startup

Urimon is developing a multi-disease early warning system based on urinary microRNA profiling

Startup

CeraVx is advancing next-generation drug delivery technologies with its proprietary microneedle drug-delivery platform

Podcast

MORE

Tim Knotnerus

Apr 29, 2026

Tim Knotnerus is de Nederlandse CEO en praat met Henk Jan Out over het bedrijf, de beursgang, leiderschap en nog veel meer. Deze podcast is live opgenomen tijdens het Innovation for Health congres eerder dit jaar.

Leaders in Life Sciences: Dé podcast over leiders in Life Sciences.

Peter Ketelaar

Peter Ketelaar is voorzitter van Life Cooperative

Jorg Janssen

Jorg Janssen is Managing Director van Lygature

Dimitri de Vreeze

Dimitri de Vreeze is CEO van DSM-Firmenich.

MORE

Podcast

MORE

Tim Knotnerus

Apr 29, 2026

Tim Knotnerus is de Nederlandse CEO en praat met Henk Jan Out over het bedrijf, de beursgang, leiderschap en nog veel meer. Deze podcast is live opgenomen tijdens het Innovation for Health congres eerder dit jaar.

Leaders in Life Sciences: Dé podcast over leiders in Life Sciences.

Peter Ketelaar

Peter Ketelaar is voorzitter van Life Cooperative

Jorg Janssen

Jorg Janssen is Managing Director van Lygature

Dimitri de Vreeze

Dimitri de Vreeze is CEO van DSM-Firmenich.

MORE

Podcast

MORE

Tim Knotnerus

Apr 29, 2026

Tim Knotnerus is de Nederlandse CEO en praat met Henk Jan Out over het bedrijf, de beursgang, leiderschap en nog veel meer. Deze podcast is live opgenomen tijdens het Innovation for Health congres eerder dit jaar.

Leaders in Life Sciences: Dé podcast over leiders in Life Sciences.

Peter Ketelaar

Peter Ketelaar is voorzitter van Life Cooperative

Jorg Janssen

Jorg Janssen is Managing Director van Lygature

MORE